InsidersTradesSigma
Follow the Laboratorio Farmaceutico Erfo share price and the full directors' dealings record of the company, a listed equity based in Italy. Shares are listed on the IT market, under the authority of Consob. Operating in the Health Care sector, Laboratorio Farmaceutico Erfo has recorded 12 public disclosures. Market capitalisation: €9.4m. The latest transaction was filed on 29 July 2026 (Grant). Among the most active insiders: MARCO CAMPAGNANO. All data is free.
12
Insider Decl.
n/a
Thresholds
€28,640
3 ops.
Buy Volume
€515,940
3 ops.
Sell Volume
36Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,946 of 29,062 companies
59.4
score / 100
Value53
Quality66
FCF yld-17%
Earn yld3.9%
EV/EBITDA5.5x
ROE9.2%
Gross mgn70%
Net mgn4.0%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 July 2026
Declarations12 total
10,000 shares@ €1.1038.4% of flowShareISIN IT0005497885CONSOB:185448
8,000 shares@ €1.1030.7% of flowShareISIN IT0005497885CONSOB:185248
8,000 shares@ €1.10530.9% of flowShareISIN IT0005497885CONSOB:184926
322,000 shares@ €1.555.33% mcap100.0% of flowShareISIN IT0005497885CONSOB:175561
1,000 shares@ €1.300.014% mcap100.0% of flowShareOTCISIN IT0005497885CONSOB:171451
11,000 shares@ €1.41270.17% mcap100.0% of flowShareOTCISIN IT0005497885CONSOB:169512
12 of 12 declarations
About Laboratorio Farmaceutico Erfo
Laboratorio Farmaceutico Erfo is a company focused on the development and manufacturing of pharmaceutical products. It operates in the XMIL market.